📰 Pharm Co News
Pharm Co News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharm Co. Real-time updates on events, politics, business and more.
January 4, 2023
Stuart Therapeutics, Inc., (hereinafter Stuart) announces that it has entered into a license agreement with AJU Pharm Co. Ltd. (hereinafter AJU), for Stuarts c
January 3, 2023
/PRNewswire/ -- Stuart Therapeutics, Inc., (hereinafter Stuart) announces that it has entered into a license agreement with AJU Pharm Co. Ltd. (hereinafter...
January 3, 2023
/PRNewswire/ -- Stuart Therapeutics, Inc., (hereinafter Stuart) announces that it has entered into a license agreement with AJU Pharm Co. Ltd. (hereinafter...
January 3, 2023
STUART, Fla., Jan. 3, 2023 /PRNewswire/ -- Stuart Therapeutics, Inc., (hereinafter Stuart) announces that it has entered into a license agreement ...
September 29, 2022
The Supreme Court has granted a temporary emergency stay of a lower court order that Novartis Pharmaceuticals says ...
July 8, 2022
On June 21, in Novartis Pharmaceuticals Corporation v. Accord Healthcare, Inc., a reshuffled Federal Circuit panel reversed course on rehearing to find that a negative claim limitation...
June 30, 2022
A U.S. appeals court overruled its prior decision, deciding that the patent for Novartis AG’s blockbuster drug Gilenya ...
June 29, 2022
In Novartis Pharmaceuticals Corp. v. Accord Healthcare, Inc., the U.S. Court of Appeals for the Federal Circuit ("Federal Circuit") held patent claims invalid for lack of written description...
June 29, 2022
In Novartis Pharmaceuticals Corp. v. Accord Healthcare, Inc., the U.S. Court of Appeals for the Federal Circuit (“Federal Circuit”) held patent claims invalid for lack of written...
June 24, 2022
Federal Circuit invalidated a patent for lack of written description under 35 U.S.C. § 112, and in doing so clarified its standard for evaluating written description of so-called negative limitations. Novartis Pharm. Corp. v. Accord Healthcare, Inc.